Kennedy Lewis Closes Secured Debt Financing For Rapid Micro Biosystems, Inc.
May 22, 2020 – New York, NY – Kennedy Lewis Investment Management (“Kennedy Lewis”), an opportunistic credit manager, completed a significant commitment to Rapid Micro Biosystems, Inc. (“Rapid Micro”) in the form of a senior secured debt facility as part of the recent $120 million total debt and equity financing. The proceeds of the financing will enable Rapid Micro to meet growing demand for its Growth Direct automated microbial detection platform and to support new product development for pandemic response.
Rapid Micro, headquartered in Lowell, Massachusetts, is the leading provider of fully automated, high-throughput, rapid microbial detection technology for biopharmaceutical manufacturing. Rapid Micro is currently used by the majority of the top 20 global biopharmaceutical companies globally.
About Kennedy Lewis
Kennedy Lewis is an opportunistic credit manager founded in 2017 by David K. Chene and Darren L. Richman. The Firm pursues event-driven situations in which a catalyst may unlock value and focuses primarily on corporate and structured credit opportunities in North America and Europe.
Related posts
July 15, 2021 – New York, NY – Kennedy Lewis Investment Management LLC (“Kennedy Lewis”), a leading opportunistic credit manager, and York Capital Management Global Advisors, LLC (“York”), a global private investment firm, today announced the closing of the previously announced strategic partnership, Generate Advisors, LLC (“Generate Advisors”). About Kennedy Lewis Kennedy Lewis is an opportunistic credit manager founded in 2017 by David K. Chene and Darren L. Richman with approximately $7 billion under management across private funds and CLOs. Kennedy Lewis’ private funds primarily focus on middle-market companies facing disruption, whether it be cyclical, secular or regulatory related. The firm…
June 30, 2021 – Redmond, WA – EchoNous, the leader in portable AI-guided ultrasound tools and software, announced it has raised $60 million in funding from Kennedy Lewis Investment Management (“Kennedy Lewis”), a leading opportunistic credit manager with a strong track record of supporting innovative life sciences companies. The investment from Kennedy Lewis combines senior secured debt and equity and builds on the support of KKR, which has been EchoNous’ principal investor since 2015. Proceeds from the financing will help fuel the commercial launch of Kosmos, EchoNous’ flagship device. Kosmos is the first AI-guided point-of-care ultrasound (POCUS) system to provide diagnostic-quality imaging on…
June 28, 2021 – New York – Kennedy Lewis Investment Management LLC (“Kennedy Lewis”), a leading opportunistic credit manager, has hired David Valiaveedan and Brieanne Nikrandt as Managing Directors to lead the firm’s homebuilder financing strategy. Mr. Valiaveedan and Ms. Nikrandt joined Kennedy Lewis from DW Partners where they led residential investments since 2015. Mr. Valiaveedan has over 30 years of experience in real estate focused on the structuring and placement of debt and equity for public and private companies across the homebuilding, multifamily, office and hotel segments. While at DW Partners, Mr. Valiaveedan formed and led its homebuilder and land development investment…